JBF Capital’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,150
Closed -$186K 80
2025
Q2
$186K Hold
13,150
0.03% 55
2025
Q1
$316K Hold
13,150
0.06% 46
2024
Q4
$491K Hold
13,150
0.08% 48
2024
Q3
$657K Hold
13,150
0.1% 55
2024
Q2
$456K Hold
13,150
0.07% 62
2024
Q1
$719K Hold
13,150
0.12% 54
2023
Q4
$563K Hold
13,150
0.11% 48
2023
Q3
$342K Hold
13,150
0.08% 47
2023
Q2
$315K Hold
13,150
0.07% 49
2023
Q1
$180K Hold
13,150
0.04% 60
2022
Q4
$183K Buy
13,150
+2,920
+29% +$41.2K 0.05% 52
2022
Q3
$63K Buy
+10,230
New +$74.2K 0.02% 65

Other funds holding BHVN

JBF Capital's BHVN Position: Q3 2025 in Review

JBF Capital sold out of Biohaven (BHVN) in Q3 2025, closing a stake of 13,150 shares — an estimated $186K sold.

JBF Capital first reported a position in BHVN in Q3 2022 and held it in 12 quarters. The position peaked at $719K in Q1 2024. 264 funds tracked by Wall St. Rank hold BHVN as of Q3 2025.

  • JBF Capital reported no remaining Biohaven position as of Q3 2025 after selling out during the quarter.
  • JBF Capital sold 13,150 Biohaven shares in Q3 2025, an estimated $186K.
  • JBF Capital first reported a position in Biohaven in Q3 2022 and held it in 12 quarters.
  • JBF Capital's Biohaven position peaked at $719K in Q1 2024.
  • 264 funds tracked by Wall St. Rank held Biohaven as of Q3 2025.

Based on JBF Capital's 13F filing for Q3 2025, filed 13 Nov 2025.